News | June 24, 2024
MediPharm Labs acquires advanced medical cannabis delivery method technology from Remidose Aerosols
Transaction is non-dilutive, with 100% performance-based payment through a royalty model
Transaction is non-dilutive, with 100% performance-based payment through a royalty model
The Issue opened on June 18, 2024 and closed on June 21, 2024
_256_384.jpg)
Cipla had earlier invested € 15 million in Ethris in 2022
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
Private financing round supported by Fidelity Management & Research Company, T. Rowe Price and Durable Capital Partners
This strategic decision will unlock significant value for our scientific and industrial products business
Scientific consensus is that there is no consistent or reliable evidence that ranitidine increases the risk of any cancer and GSK will continue to vigorously defend itself against all claims
Profit Before Tax is Rs. 220 crore, registering a commendable 64% growth
Keimed is a leading wholesale pharma distribution with industry leading operating metrics
Commercial terms include research funding and milestones and/or royalty payments to Evotec based on the success of the program
Subscribe To Our Newsletter & Stay Updated
